Funding for this research was provided by:
Health Technology Assessment Programme (Ref 14/140/63)
Received: 2 December 2021
Accepted: 21 March 2022
First Online: 12 May 2022
: ACL SNNAP obtained central ethical approval from South Central – Oxford C Research Ethics Committee (REC reference: 16/SC/0502), and local ethical approval was obtained at each recruiting site before recruitment commenced there. The trial is sponsored by the University of Oxford. ACL SNNAP is registered with the International Standard Randomised Controlled Trials database, ISRCTN reference ISRCTN10110685. Written informed consent was obtained from each participant before they agreed to participate in the study.
: Not applicable.
: The authors declare that they have no competing interests.